Polymer-Based Topical Drug Delivery: Advances in Skin Penetration and Targeted Therapy
DOI:
https://doi.org/10.55006/biolsciences.2026.6204Keywords:
Hydrogels, Polymers, Drug delivery, Transdermal, TopicalAbstract
Topical drug delivery systems have advanced significantly with the incorporation of polymer-based formulations, providing better patient compliance, controlled drug release, and increased therapeutic efficacy. Lipid-polymer hybrid nanoparticles (LPNPs) are particularly highlighted for site-specific delivery of multiple medications, owing to their structural advantages and controlled-release capabilities. The multifunctional role of polymers in stabilizing therapeutic proteins and enhancing skin penetration is explored, along with innovations such as pH-sensitive, temperature-sensitive, and biodegradable polymer systems. Emerging technologies like 3D printing are also discussed for their potential to revolutionize personalized topical therapies. Applications in dermatology, wound healing, and cosmetics underscore the versatility of polymeric systems. Numerous polymeric systems, including hydrogels, emulgels, nanogels, polymeric nanoparticles, microspheres, and film-forming systems, are highly effective at improving drug localization, enhancing skin retention, and achieving controlled release. The comparative analysis of these systems indicates that nanoparticles or nanogels will provide superior tissue penetration and targeted delivery, while hydrogels or emulgels will provide increased patient compliance and a prolonged duration of action at the site of topical administration. Challenges associated with scaling up manufacturing processes, polymer-related toxicity, regulatory approval, and long-term stability will continue to restrict the translation of these technologies to clinical use. Safety concerns, particularly toxicity and long-term bioaccumulation of certain polymer systems, are critically examined.
Downloads
References
1. Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5:205-18.
2. Adepu S, Ramakrishna S. Controlled drug delivery systems: Current status and future directions. Molecules. 2021;26:5905.
3. Qelliny MR, Mustafa WW, Al Fatease A, Alamri AH, Alany R, Abdelkader H. Biofunctional excipients: Their emerging role in overcoming the inherent poor biopharmaceutical characteristics of drugs. Pharmaceutics. 2025;17:598.
4. Hubbell JA. Synthetic biodegradable polymers for tissue engineering and drug delivery. Curr Opin Solid State Mater Sci. 1998;3:246-51.
5. Thang NH, Chien TB, Cuong DX. Polymer-based hydrogels applied in drug delivery: An overview. Gels. 2023;9:523.
6. Antonara L, Triantafyllopoulou E, Chountoulesi M, Pippa N, Dallas PP, Rekkas DM. Lipid-based drug delivery systems: Concepts and recent advances in transdermal applications. Nanomaterials (Basel). 2025;15:1326.
7. Parhi R. Cross-linked hydrogel for pharmaceutical applications: A review. Adv Pharm Bull. 2017;7:515-30.
8. Zöller K, To D, Bernkop-Schnürch A. Biomedical applications of functional hydrogels: Innovative developments, relevant clinical trials and advanced products. Biomaterials. 2025;312:122718.
9. Mishra S, Shah H, Patel A, Tripathi SM, Malviya R, Prajapati BG. Applications of bioengineered polymer in the field of nano-based drug delivery. ACS Omega. 2024;9:81-96.
10. Ahsan A, Tian WX, Farooq MA, Khan DH. An overview of hydrogels and their role in transdermal drug delivery. Int J Polym Mater Polym Biomater. 2021;70:574-84.
11. Jacob S, Nair AB, Shah J, Sreeharsha N, Gupta S, Shinu P. Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management. Pharmaceutics. 2021;13:357.
12. Rashid F, Carter P, Childs S. Overview of hydrogels and the use of hyaluronic acid-based hydrogels in pharmaceutical transdermal delivery systems and topical cosmetic skin applications. Cosmetics. 2025;12:265.
13. Kesharwani P, Bisht A, Alexander A, Dave V, Sharma S. Biomedical applications of hydrogels in drug delivery system: An update. J Drug Deliv Sci Technol. 2021;66:102914.
14. Milutinov J, Krstonošić V, Ćirin D, Pavlović N. Emulgels: Promising carrier systems for food ingredients and drugs. Polymers (Basel). 2023;15:2302.
15. Yadav SK, Mishra MK, Tiwari A, Shukla A. Emulgel: A new approach for enhanced topical drug delivery. Int J Curr Pharm Res. 2017;9:15-20.
16. Sah SK, Badola A, Nayak BK. Emulgel: Magnifying the application of topical drug delivery. Indian J Pharm Biol Res. 2017;5:25-33.
17. Patel BM, Kuchekar AB, Pawar SR. Emulgel approach to formulation development: A review. Biosci Biotechnol Res Asia. 2021;18:459-65.
18. Cevc G, Mazgareanu S, Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int J Pharm. 2008;360:29-39.
19. Shi YY, Li X, Li Z, Sun J, Gao T, Wei G, et al. Nano-formulations in disease therapy: Designs, advances, challenges, and future directions. J Nanobiotechnol. 2025;23:396.
20. Tripathi SM, Mishra S, Malviya R, Ojha S. Blood brain barrier and nanotechnology for neurodegenerative disorders. In: Bioactive Compounds Targeting Neurodegenerative Disorders. Sharjah: Bentham Science Publishers; 2025. p. 77-93.
21. da Cruz Ludwig J, Grigoletto DF, Renzi DF, Abraham WR, de Paula D, Khalil NM. Hydrogels and nanogels: Effectiveness in dermal applications. Beilstein J Nanotechnol. 2025;16:1216-33.
22. Burns J, Buck AC, D'Souza S, Dube A, Bardien S. Nanophytomedicines as therapeutic agents for Parkinson's disease. ACS Omega. 2023;8:42045-61.
23. Lengyel M, Kállai-Szabó N, Antal V, Laki AJ, Antal I. Microparticles, microspheres, and microcapsules for advanced drug delivery. Sci Pharm. 2019;87:20.
24. da Silva RYP, de Menezes DLB, Oliveira VS, Converti A, de Lima ÁAN. Microparticles in the development and improvement of pharmaceutical formulations: An analysis of in vitro and in vivo studies. Int J Mol Sci. 2023;24:5441.
25. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004;123:168-76.
26. Pünnel LC, Lunter DJ. Film-forming systems for dermal drug delivery. Pharmaceutics. 2021;13:932.
27. Rathod D, Deshmukh A, Mahale A. Film-forming sprays for topical drug delivery: A review of current developments and future perspectives. Int J Pharm Sci. 2025;3:1154-63.
28. Kong X, Zhao Y, Quan P, Fang L. Development of a topical ointment of betamethasone dipropionate loaded nanostructured lipid carrier. Asian J Pharm Sci. 2016;11:248-54.
29. Shen Y, Ling X, Jiang W, Du S, Lu Y, Tu J. Formulation and evaluation of cyclosporin A emulgel for ocular delivery. Drug Deliv. 2015;22:911-7.
30. Naga Sravan Kumar Varma V, Maheshwari PV, Navya M, Reddy SC, Shivakumar HG, Gowda DV. Calcipotriol delivery into the skin as emulgel for effective permeation. Saudi Pharm J. 2014;22:591-9.
31. Sabu KR, Basarkar GD. Formulation, development and in-vitro evaluation of terbinafine hydrochloride emulgel for topical fungal infection. Int J Pharm Sci Rev Res. 2013;21:168-73.
32. Pathan IB, Munde SJ, Shelke S, Ambekar W, Mallikarjuna Setty C. Curcumin loaded fish scale collagen-HPMC nanogel for wound healing application: Ex-vivo and in-vivo evaluation. Int J Polym Mater Polym Biomater. 2019;68:165-74.
33. El-Feky GS, El-Banna ST, El-Bahy GS, Abdelrazek EM, Kamal M. Alginate coated chitosan nanogel for the controlled topical delivery of silver sulfadiazine. Carbohydr Polym. 2017;177:194-202.
34. Jacobs GA, Gerber M, Malan MM, Du Preez JL, Fox LT, Du Plessis J. Topical delivery of acyclovir and ketoconazole. Drug Deliv. 2016;23:641-51.
35. Brito S, Baek M, Bin BH. Skin structure, physiology, and pathology in topical and transdermal drug delivery. Pharmaceutics. 2024;16:1403.
36. Caldwell J, Gardner I, Swales N. An introduction to drug disposition: The basic principles of absorption, distribution, metabolism, and excretion. Toxicol Pathol. 1995;23:102-14.
37. Alkilani AZ, McCrudden MTC, Donnelly RF. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438-70.
38. Swain SK, Sambamoorthy U, Jena BR, Naidu N, Pilla AT, Chunduru H, et al. Controlled drug delivery systems: Advancements and recent patents. Int J Pharm Sci Nanotechnol. 2025;18:7879-94.
39. Champeau M, Vignoud S, Mortier L, Mordon S. Photodynamic therapy for skin cancer: How to enhance drug penetration? J Photochem Photobiol B. 2019;197:111544.
40. Crasta A, Painginkar T, Sreedevi A, Pawar SD, Badamane Sathyanarayana M, Vasantharaju SG, et al. Transdermal drug delivery system: A comprehensive review of innovative strategies, applications, and regulatory perspectives. OpenNano. 2025;24:100245.
41. Guillot AJ, Martínez-Navarrete M, Garrigues TM, Melero A. Skin drug delivery using lipid vesicles: A starting guideline for their development. J Control Release. 2023;355:624-54.
42. Scheuplein RJ. Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility. J Invest Dermatol. 1965;45:334-46.
43. Subedi RK, Oh SY, Chun MK, Choi HK. Recent advances in transdermal drug delivery. Arch Pharm Res. 2010;33:339-51.
44. Ng KW. Penetration enhancement of topical formulations. Pharmaceutics. 2018;10:51.
45. Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394.
46. Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science. 2004;303:1818-22.
47. Bouissou C, Rouse JJ, Price R, Van Der Walle CF. The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release. Pharm Res. 2006;23:1295-305.
48. Makadia HK, Siegel SJ. Poly(lactic-co-glycolic acid) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3:1377-97.
49. Sharma M, Sharma R, Jain DK. Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs. Scientifica (Cairo). 2016;2016:8525679.
50. Vaseem RS, D'Cruz A, Shetty S, Hafsa, Vardhan A, Shenoy SR, et al. Transdermal drug delivery systems: A focused review of the physical methods of permeation enhancement. Adv Pharm Bull. 2024;14:67-85.
51. Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149-73.
52. Zeng L, Huang F, Zhang Q, Liu J, Quan D, Song W. Molecular perspective of efficiency and safety problems of chemical enhancers: Bottlenecks and recent advances. Drug Deliv Transl Res. 2022;12:1376-94.
53. Dave K, Krishna Venuganti VV. Dendritic polymers for dermal drug delivery. Ther Deliv. 2017;8:1077-96.
54. Haq A, Chandler M, Michniak-Kohn B. Solubility-physicochemical-thermodynamic theory of penetration enhancer mechanism of action. Int J Pharm. 2020;575:118920.
55. Garbett NC, Chaires JB. Thermodynamic studies for drug design and screening. Expert Opin Drug Discov. 2012;7:299-314.
56. Bouwstra JA, Nădăban A, Bras W, McCabe C, Bunge A, Gooris GS. The skin barrier: An extraordinary interface with an exceptional lipid organization. Prog Lipid Res. 2023;92:101252.
57. Liu Y, Li M, Xie D, Chen G, Zhao N, Luo Z. Research progress of penetration enhancers in transdermal drug delivery systems: Multidimensional exploration from mechanisms to clinical application. Int J Pharm X. 2025;10:100468.
58. Han Y, Jin ZY, Zhang DS, Hu BB, Li ZQ, Jing YS, et al. Application of polymers in promoting transdermal absorption. Mater Today Chem. 2022;26:101204.
59. Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, et al. Polymeric nanoparticles for drug delivery. Chem Rev. 2024;124:5505-616.
Downloads
CITATION
Published
Issue
Section
License
Copyright (c) 2026 Mansi Upadhyay, Noureen Jahan, Mohammad Saliq, Madhu Singh, Preeti Prasad

This work is licensed under a Creative Commons Attribution 4.0 International License.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

